Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report.

Takada K, Sugita S, Murase K, Kikuchi T, Oomori G, Ito R, Hayasaka N, Miyanishi K, Iyama S, Ikeda H, Kobune M, Emori M, Kato J, Hasegawa T.

Thorac Cancer. 2019 Oct 16. doi: 10.1111/1759-7714.13215. [Epub ahead of print]

PMID:
31617320
2.

Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment.

Takada K, Murase K, Nakamura H, Hayasaka N, Arihara Y, Iyama S, Ikeda H, Emori M, Sugita S, Nakamura K, Miyanishi K, Kobune M, Kato J.

Intern Med. 2019 Oct 15;58(20):3009-3012. doi: 10.2169/internalmedicine.2790-19. Epub 2019 Jun 27.

3.

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.

Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K, Ishizuka S, Sato N, Saruwatari K, Saeki S, Tomita Y, Sakagami T.

J Clin Med. 2019 May 29;8(6). pii: E762. doi: 10.3390/jcm8060762.

4.

EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.

Miura S, Kobune M, Horiguchi H, Kikuchi S, Iyama S, Murase K, Goto A, Ikeda H, Takada K, Miyanishi K, Kato J.

Blood Cells Mol Dis. 2019 Sep;78:1-8. doi: 10.1016/j.bcmd.2019.04.014. Epub 2019 Apr 30.

PMID:
31082798
5.

[Treatment of POEMS syndrome with lenalidomide and dexamethasone].

Goto A, Iyama S, Sugama Y, Yoshida M, Ibata S, Tatekoshi A, Fujita C, Kikuchi S, Ikeda H, Murase K, Takada K, Kato J, Kobune M.

Rinsho Ketsueki. 2019;60(4):308-313. doi: 10.11406/rinketsu.60.308. Japanese.

PMID:
31068561
6.

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.

Hayasaka N, Takada K, Nakamura H, Arihara Y, Kawano Y, Osuga T, Murase K, Kikuchi S, Iyama S, Emori M, Sugita S, Hasegawa T, Takasawa A, Miyanishi K, Kobune M, Kato J.

Sci Rep. 2019 Apr 8;9(1):5759. doi: 10.1038/s41598-019-42300-z.

7.

miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells.

Yoshida M, Horiguchi H, Kikuchi S, Iyama S, Ikeda H, Goto A, Kawano Y, Murase K, Takada K, Miyanishi K, Kato J, Kobune M.

PLoS One. 2019 Mar 5;14(3):e0213220. doi: 10.1371/journal.pone.0213220. eCollection 2019.

8.

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Immun Inflamm Dis. 2019 Mar;7(1):3-6. doi: 10.1002/iid3.238. Epub 2018 Nov 21.

9.

Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer.

Nakamura H, Takada K, Arihara Y, Hayasaka N, Murase K, Iyama S, Kobune M, Miyanishi K, Kato J.

Cancer Gene Ther. 2019 Sep;26(9-10):313-322. doi: 10.1038/s41417-018-0056-8. Epub 2018 Nov 7.

PMID:
30401882
10.

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K.

Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020.

PMID:
30396984
11.

High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma.

Ibata S, Kobune M, Kikuchi S, Yoshida M, Miura S, Horiguchi H, Murase K, Iyama S, Takada K, Miyanishi K, Kato J.

Oncotarget. 2018 May 18;9(38):25127-25135. doi: 10.18632/oncotarget.25350. eCollection 2018 May 18.

12.

Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.

Iesato K, Hori T, Yoto Y, Yamamoto M, Inazawa N, Kamo K, Ikeda H, Iyama S, Hatakeyama N, Iguchi A, Sugita J, Kobayashi R, Suzuki N, Tsutsumi H.

Pediatr Int. 2018 Jun;60(6):547-552. doi: 10.1111/ped.13551.

PMID:
29542206
13.

Development of the Self-Regulated Learning Scale in Clinical Nursing Practice for nursing students: Consideration of its reliability and validity.

Iyama S, Maeda H.

Jpn J Nurs Sci. 2018 Jul;15(3):226-236. doi: 10.1111/jjns.12191. Epub 2017 Nov 20.

PMID:
29152853
14.

Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma.

Arihara Y, Takada K, Kamihara Y, Hayasaka N, Nakamura H, Murase K, Ikeda H, Iyama S, Sato T, Miyanishi K, Kobune M, Kato J.

Oncotarget. 2017 Jul 22;8(39):65889-65899. doi: 10.18632/oncotarget.19508. eCollection 2017 Sep 12.

15.

[A Case of Chronic Myelogenous Leukemia That Developed Fibrous Pericarditis Owing to Nilotinib Use].

Miura S, Murase K, Sakurada A, Takada K, Iyama S, Sato T, Sato Y, Miyanishi K, Kobune M, Muranaka A, Tachibana K, Kato J.

Gan To Kagaku Ryoho. 2017 Jun;44(6):529-531. Japanese.

PMID:
28698448
16.

Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.

Iyama S, Ono M, Kawai-Nakahara H, Husni RE, Dai T, Shiozawa T, Sakata A, Kohrogi H, Noguchi M.

Lung Cancer. 2016 Dec;102:74-81. doi: 10.1016/j.lungcan.2016.10.013. Epub 2016 Oct 27.

PMID:
27987592
17.

A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma.

Ibata S, Sato T, Kuroda H, Nagamachi Y, Iyama S, Fujimi A, Kamihara Y, Konuma Y, Yoshida M, Tatekoshi A, Hashimoto A, Horiguchi H, Ono K, Murase K, Takada K, Miyanishi K, Kobune M, Hirayama Y, Kato J.

Cancer Chemother Pharmacol. 2016 Nov;78(5):1041-1049. Epub 2016 Oct 13.

18.

Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease.

Asano T, Matsuoka KI, Iyama S, Ohashi K, Inamoto Y, Ohwada C, Murata M, Satake A, Yoshida C, Nakase K, Mori Y, Tanimoto M.

Acta Med Okayama. 2016 Oct;70(5):429-433.

19.

Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.

Ono M, Takimoto R, Osuga T, Okagawa Y, Hirakawa M, Yoshida M, Arihara Y, Uemura N, Hayasaka N, Miura S, Matsuno T, Tamura F, Sato Y, Sato T, Iyama S, Miyanishi K, Takada K, Kobune M, Kato J.

Oncotarget. 2016 Jun 21;7(25):38586-38597. doi: 10.18632/oncotarget.9558.

20.

A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.

Iyama S, Sato T, Ohnishi H, Kanisawa Y, Ohta S, Kondo T, Mori A, Tsutsumi Y, Kuroda H, Kakinoki Y, Yamamoto S, Takahashi T, Shindo M, Torimoto Y, Sato K, Iwasaki H, Haseyama Y, Kohda K, Nagamachi Y, Hirayama Y, Sakai H, Hirata Y, Fukuhara T, Ikeda H, Kobune M, Kato J, Kurosawa M.

Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):23-30.e2. doi: 10.1016/j.clml.2016.09.009. Epub 2016 Sep 17.

PMID:
27727135
21.

Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.

Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y, Uemura N, Arihara Y, Sato Y, Tamura F, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.

J Natl Cancer Inst. 2016 Sep 14;108(9). pii: djw210. doi: 10.1093/jnci/djw210. Print 2016 Sep. Retraction in: J Natl Cancer Inst. 2016 Sep 14;108(9):.

PMID:
27628655
22.

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.

Kamihara Y, Takada K, Sato T, Kawano Y, Murase K, Arihara Y, Kikuchi S, Hayasaka N, Usami M, Iyama S, Miyanishi K, Sato Y, Kobune M, Kato J.

Oncotarget. 2016 Sep 27;7(39):64330-64341. doi: 10.18632/oncotarget.11830.

23.

[Treatment Outcomes of Adult-Onset Ewing Sarcoma: A Single-Center Retrospective Study of Five Cases].

Murase K, Takada K, Kamihara Y, Usami M, Yoshida M, Tatekoshi A, Hashimoto A, Arihara Y, Hayasaka N, Miura S, Iyama S, Sato T, Sato Y, Miyanishi K, Kobune M, Emori M, Kaya M, Yamashita T, Sugita S, Hasegawa T, Kato J.

Gan To Kagaku Ryoho. 2016 Aug;43(8):1015-8. Japanese.

PMID:
27539047
24.

Isoform D of vascular endothelial growth factor in systemic capillary leak syndrome: a case report.

Ibata S, Sato T, Takada K, Tatekoshi A, Hashimoto A, Kamihara Y, Jomen W, Horiguchi H, Ono K, Murase K, Iyama S, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

J Med Case Rep. 2016 May 24;10:125. doi: 10.1186/s13256-016-0894-7.

25.

Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).

Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, Eto T, Tsuda H, Fujisaki T, Miyamoto T, Tsuneyoshi N, Iyama S, Nagafuji K, Harada M.

Int J Hematol. 2016 Jun;103(6):676-85. doi: 10.1007/s12185-016-1976-4. Epub 2016 Mar 21.

PMID:
27084252
26.

Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.

Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y, Uemura N, Arihara Y, Sato Y, Tamura F, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.

J Natl Cancer Inst. 2016 Apr 13;108(8). doi: 10.1093/jnci/djw038. Print 2016 Aug.

27.

Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells.

Hashimoto A, Sato T, Iyama S, Yoshida M, Ibata S, Tatekoshi A, Kamihara Y, Horiguchi H, Murase K, Kawano Y, Takada K, Miyanishi K, Kobune M, Ichimiya S, Kato J.

PLoS One. 2016 Mar 31;11(3):e0152823. doi: 10.1371/journal.pone.0152823. eCollection 2016.

28.

[Neurolymphomatosis of the sciatic nerve diagnosed by FDG-PET/CT].

Usami M, Murase K, Takada K, Iijima K, Yoshida M, Tatekoshi A, Hashimoto A, Iyama S, Sato T, Kobune M, Takimoto R, Kaya M, Yamashita T, Morita R, Hasegawa T, Kato J.

Rinsho Ketsueki. 2016 Jan;57(1):52-5. doi: 10.11406/rinketsu.57.52. Japanese.

PMID:
26861105
29.

Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.

Horiguchi H, Kobune M, Kikuchi S, Yoshida M, Murata M, Murase K, Iyama S, Takada K, Sato T, Ono K, Hashimoto A, Tatekoshi A, Kamihara Y, Kawano Y, Miyanishi K, Sawada N, Kato J.

Haematologica. 2016 Apr;101(4):437-47. doi: 10.3324/haematol.2015.134932. Epub 2016 Jan 22.

30.

[RS3PE syndrome associated with senile Epstein-Barr virus-positive diffuse large B cell lymphoma of a patient with colon cancer].

Shimoyama S, Kuroda H, Yoshida M, Usami M, Sakamoto H, Yamada M, Fujii S, Maeda M, Fujita M, Nakano T, Kanari Y, Iyama S, Kato J.

Rinsho Ketsueki. 2015 Nov;56(11):2329-35. doi: 10.11406/rinketsu.56.2329. Review. Japanese.

PMID:
26666720
31.

Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma.

Shiozawa T, Iyama S, Toshima S, Sakata A, Usui S, Minami Y, Sato Y, Hizawa N, Noguchi M.

Virchows Arch. 2016 Feb;468(2):179-90. doi: 10.1007/s00428-015-1863-z. Epub 2015 Oct 29.

32.

[Therapy-related myelodysplastic syndrome as a late adverse event of definitive chemoradiotherapy for esophageal and oropharyngeal cancer].

Kamihara Y, Sato Y, Takada K, Okagawa Y, Iyama S, Sato T, Miyanishi K, Takimoto R, Kobune M, Kato J.

Nihon Shokakibyo Gakkai Zasshi. 2015;112(9):1664-73. doi: 10.11405/nisshoshi.112.1664. Review. Japanese.

PMID:
26346357
33.

[Successful Hematopoietic Cell Transplantation Following Azacitidine Treatment in an Acute Myeloid Leukemia Patient with t(3;3)(q21;q26.2) Translocation and Marked Thrombocythemia].

Yoshida M, Kuroda H, Shimoyama S, Usami M, Yamada M, Fujii S, Maeda M, Fujita M, Kanari Y, Sato M, Jomen W, Iyama S, Kato J.

Gan To Kagaku Ryoho. 2015 Aug;42(8):1013-7. Japanese.

PMID:
26321721
34.

Stratifin accelerates progression of lung adenocarcinoma at an early stage.

Shiba-Ishii A, Kim Y, Shiozawa T, Iyama S, Satomi K, Kano J, Sakashita S, Morishita Y, Noguchi M.

Mol Cancer. 2015 Jul 30;14:142. doi: 10.1186/s12943-015-0414-1.

35.

Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.

Fujimi A, Kamihara Y, Hashimoto A, Kanisawa Y, Nakajima C, Hayasaka N, Yamada S, Okuda T, Minami S, Ono K, Iyama S, Kato J.

Int J Hematol. 2015 Oct;102(4):471-6. doi: 10.1007/s12185-015-1806-0. Epub 2015 May 13.

PMID:
25964100
36.

Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.

Hirayama Y, Ishitani K, Sato Y, Iyama S, Takada K, Murase K, Kuroda H, Nagamachi Y, Konuma Y, Fujimi A, Sagawa T, Ono K, Horiguchi H, Terui T, Koike K, Kusakabe T, Sato T, Takimoto R, Kobune M, Kato J.

Int J Clin Oncol. 2015 Oct;20(5):866-71. doi: 10.1007/s10147-015-0810-y. Epub 2015 Mar 12.

PMID:
25762165
37.

A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer.

Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2015 Mar;75(3):587-94. doi: 10.1007/s00280-014-2672-9. Epub 2015 Jan 11.

PMID:
25577134
38.

RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.

Tamura F, Sato Y, Hirakawa M, Yoshida M, Ono M, Osuga T, Okagawa Y, Uemura N, Arihara Y, Murase K, Kawano Y, Iyama S, Takada K, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Kato J.

Gastric Cancer. 2016 Jan;19(1):85-97. doi: 10.1007/s10120-014-0454-z. Epub 2014 Dec 23.

PMID:
25532910
39.

Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab.

Tatekoshi A, Sato T, Ibata S, Hashimoto A, Kamihara Y, Horiguchi H, Ono K, Takada K, Iyama S, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2014 Nov;55(11):2271-6. Japanese.

PMID:
25501406
40.

Efficacy of Enteral Supplementation Enriched with Glutamine, Fiber, and Oligosaccharide on Mucosal Injury following Hematopoietic Stem Cell Transplantation.

Iyama S, Sato T, Tatsumi H, Hashimoto A, Tatekoshi A, Kamihara Y, Horiguchi H, Ibata S, Ono K, Murase K, Takada K, Sato Y, Hayashi T, Miyanishi K, Akizuki E, Nobuoka T, Mizugichi T, Takimoto R, Kobune M, Hirata K, Kato J.

Case Rep Oncol. 2014 Oct 22;7(3):692-9. doi: 10.1159/000368714. eCollection 2014 Sep.

41.

A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies.

Sakai T, Kohda K, Konuma Y, Hiraoka Y, Ichikawa Y, Ono K, Horiguchi H, Tatekoshi A, Takada K, Iyama S, Kato J.

Int J Hematol. 2014 Dec;100(6):592-8. doi: 10.1007/s12185-014-1677-9. Epub 2014 Sep 24.

PMID:
25248408
42.

Radiation-induced leiomyosarcoma of the prostate after brachytherapy for prostatic adenocarcinoma.

Horiguchi H, Takada K, Kamihara Y, Ibata S, Iyama S, Sato T, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kobayashi K, Hirayama Y, Masumori N, Hasegawa T, Kato J.

Case Rep Oncol. 2014 Aug 16;7(2):565-70. doi: 10.1159/000366294. eCollection 2014 May.

43.

[Effective treatment of metastatic rhabdomyosarcoma with pazopanib].

Hashimoto A, Takada K, Takimoto R, Horiguchi H, Sato T, Iyama S, Murase K, Ono K, Tatekoshi A, Hayashi T, Miyanishi K, Sato Y, Kobune M, Hirayama Y, Kitamura H, Nakanishi K, Masumori N, Hasegawa T, Kato J.

Gan To Kagaku Ryoho. 2014 Aug;41(8):1041-4. Japanese.

PMID:
25132042
44.

Successful treatment with entecavir for reactivation of hepatitis B virus following systemic chemotherapy in a hepatitis B surface antigen-negative patient with colorectal cancer.

Okagawa Y, Takada K, Hisai H, Koshiba Y, Wada H, Miyazaki E, Kanari Y, Kawano Y, Iyama S, Hayashi T, Sato T, Sato Y, Miyanishi K, Kobune M, Takimoto R, Kato J.

Intern Med. 2014;53(16):1759-62. Epub 2014 Aug 15.

45.

Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma.

Fujimi A, Kamihara Y, Kanisawa Y, Hashimoto A, Nakajima C, Hayasaka N, Uemura N, Okuda T, Minami S, Iyama S, Takada K, Sato T, Hara A, Iwata Y, Furuichi K, Wada T, Kato J.

Int J Hematol. 2014 Nov;100(5):490-3. doi: 10.1007/s12185-014-1652-5. Epub 2014 Aug 6.

PMID:
25096221
46.

Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer.

Hashimoto A, Takada K, Horiguchi H, Sato T, Iyama S, Murase K, Kamihara Y, Ono K, Tatekoshi A, Hayashi T, Miyanishi K, Sato Y, Furuhata T, Kobune M, Takimoto R, Hirata K, Kato J.

Case Rep Oncol. 2014 May 17;7(2):316-22. doi: 10.1159/000363100. eCollection 2014 May.

47.

High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.

Shigematsu A, Kobayashi N, Yasui H, Shindo M, Kakinoki Y, Koda K, Iyama S, Kuroda H, Tsutsumi Y, Imamura M, Teshima T.

Biol Blood Marrow Transplant. 2014 Jun;20(6):801-5. doi: 10.1016/j.bbmt.2014.02.014. Epub 2014 Feb 22.

48.

Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.

Iyama S, Murase K, Sato T, Hashimoto A, Tatekoshi A, Horiguchi H, Kamihara Y, Ono K, Kikuchi S, Takada K, Kawano Y, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Mori S, Kato J, Yamashita T, Kato J.

Int J Hematol. 2014 Apr;99(4):471-6. doi: 10.1007/s12185-014-1530-1. Epub 2014 Feb 21.

PMID:
24557710
49.

A novel strategy inducing autophagic cell death in Burkitt's lymphoma cells with anti-CD19-targeted liposomal rapamycin.

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Kawano Y, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Blood Cancer J. 2014 Feb 7;4:e180. doi: 10.1038/bcj.2014.2.

50.

[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2013 Nov;54(11):2053-5. Japanese.

PMID:
24305538

Supplemental Content

Support Center